Table 1 Clinical features of early recurrence and non-early recurrence cohorts
Early recurrence (n = 101) | Non-early recurrence (n = 96) | P-value | |
|---|---|---|---|
Median age (years ) | 62.5 (40 to 80) | 63.0 (47 to 78) | 0.665 |
Gender (%) | 0.799 | ||
Male | 72 (71.3) | 70 (72.9) | |
Female | 29 (28.7) | 26 (27.1) | |
pT stage (%) | 0.044* | ||
T1 | 1 (1.0) | 5 (5.2) | |
T2 | 30 (29.7) | 36 (37.5) | |
T3 | 59 (58.4) | 52 (54.2) | |
T4a | 11 (10.9) | 3 (3.1) | |
pN stage (%) | < 0.001* | ||
N0 | 51 (50.5) | 74 (77.1) | |
N1 | 32 (31.7) | 17 (17.7) | |
N2 | 18 (17.8) | 5 (5.2) | |
Differentiation degree (%) | 0.017* | ||
Low | 2 (1.9) | 7 (7.3) | |
Middle | 55 (54.5) | 35 (36.5) | |
High | 44 (43.6) | 54 (56.2) | |
pTNM stage (%) | < 0.001* | ||
IB | 7 (6.9) | 20 (20.8) | |
IIA | 25 (24.8) | 33 (34.4) | |
IIB | 15 (14.9) | 21 (21.9) | |
IIIA | 8 (7.9) | 4 (4.1) | |
IIIB | 46 (45.5) | 18 (18.8) |